MaxCyte Announces Change in Major Shareholdings
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
MaxCyte ( (MXCT) ) has provided an update.
MaxCyte, Inc., a company in the biotechnology industry, has announced a change in the major holdings of its shares. The notification indicates that BlackRock, Inc. has acquired and now holds a total of 8.44% of MaxCyte’s voting rights, marking a slight decrease from the previous 8.52%. This adjustment reflects a minor shift in voting influence, potentially impacting strategic decisions and shareholder dynamics within the company.
More about MaxCyte
YTD Price Performance: -10.64%
Average Trading Volume: 44,487
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £345.1M
For detailed information about MXCT stock, go to TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.